Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Jul;35(7):1479–1483. doi: 10.1128/aac.35.7.1479

Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women.

T M Hooton 1, C Johnson 1, C Winter 1, L Kuwamura 1, M E Rogers 1, P L Roberts 1, W E Stamm 1
PMCID: PMC245194  PMID: 1929311

Abstract

We compared the safety and efficacy of a single 400-mg dose of ofloxacin, ofloxacin (200 mg) once daily for 3 days, and trimethoprim-sulfamethoxazole (160:800 mg) twice daily for 7 days for the treatment of acute uncomplicated cystitis (urinary tract infection [UTI]) in women. At 5 weeks posttreatment, 35 (81%) of 43 patients treated with single-dose ofloxacin, 40 (89%) of 45 treated with 3 days of ofloxacin, and 41 (98%) of 42 treated with trimethoprim-sulfamethoxazole were cured (P = 0.03, single-dose ofloxacin group versus trimethoprim-sulfamethoxazole group). Retreatment for symptomatic recurrent UTI was given to 7 (16%) of 43 patients initially treated with single-dose ofloxacin, 3 (7%) of 45 patients treated with 3 days of ofloxacin, and 0 of 42 patients treated with trimethoprim-sulfamethoxazole (P = 0.01, single-dose ofloxacin group versus trimethoprim-sulfamethoxazole group). There was a trend in each of the three treatment groups toward an association between persistent or recurrent episodes of significant bacteriuria and a history of UTI in the past year and with diaphragm use. Ofloxacin was more effective than trimethoprim-sulfamethoxazole in eradicating Escherichia coli from rectal cultures during or soon after therapy, but there were no differences at later follow-up visits. Adverse effects were equally common among the three treatment groups. We conclude that single-dose ofloxacin was less effective than 7 days of trimethoprim-sulfamethoxazole for treatment of uncomplicated cystitis in women, while the 3-day ofloxacin regimen and the trimethoprim-sulfamethoxazole regimen were not significantly different in efficacy.

Full text

PDF
1482

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arcieri G., Griffith E., Gruenwaldt G., Heyd A., O'Brien B., Becker N., August R. Ciprofloxacin: an update on clinical experience. Am J Med. 1987 Apr 27;82(4A):381–386. [PubMed] [Google Scholar]
  2. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  3. Block J. M., Walstad R. A., Bjertnaes A., Hafstad P. E., Holte M., Ottemo I., Svarva P. L., Rolstad T., Peterson L. E. Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. Drugs. 1987;34 (Suppl 1):100–106. doi: 10.2165/00003495-198700341-00022. [DOI] [PubMed] [Google Scholar]
  4. Counts G. W., Stamm W. E., McKevitt M., Running K., Holmes K. K., Turck M. Treatment of cystitis in women with a single dose of trimethoprim-sulfamethoxazole. Rev Infect Dis. 1982 Mar-Apr;4(2):484–490. doi: 10.1093/clinids/4.2.484. [DOI] [PubMed] [Google Scholar]
  5. Fihn S. D., Johnson C., Roberts P. L., Running K., Stamm W. E. Trimethoprim-sulfamethoxazole for acute dysuria in women: a single-dose or 10-day course. A double-blind, randomized trial. Ann Intern Med. 1988 Mar;108(3):350–357. doi: 10.7326/0003-4819-108-3-350. [DOI] [PubMed] [Google Scholar]
  6. Ganguli L. A., Keaney M. G., Gould L. J. Norfloxacin: a three-day course for the treatment of urinary tract infection. Drugs Exp Clin Res. 1985;11(3):177–179. [PubMed] [Google Scholar]
  7. Garlando F., Rietiker S., Täuber M. G., Flepp M., Meier B., Lüthy R. Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. Antimicrob Agents Chemother. 1987 Feb;31(2):354–356. doi: 10.1128/aac.31.2.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Henry N. K., Schultz H. J., Grubbs N. C., Muller S. M., Ilstrup D. M., Wilson W. R. Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women. J Antimicrob Chemother. 1986 Nov;18 (Suppl 500):103–106. doi: 10.1093/jac/18.supplement_d.103. [DOI] [PubMed] [Google Scholar]
  9. Hooton T. M., Latham R. H., Wong E. S., Johnson C., Roberts P. L., Stamm W. E. Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. Antimicrob Agents Chemother. 1989 Aug;33(8):1308–1312. doi: 10.1128/aac.33.8.1308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johnson J. R., Stamm W. E. Urinary tract infections in women: diagnosis and treatment. Ann Intern Med. 1989 Dec 1;111(11):906–917. doi: 10.7326/0003-4819-111-11-906. [DOI] [PubMed] [Google Scholar]
  11. Leigh D. A., Walsh B., Harris K., Hancock P., Travers G. Pharmacokinetics of ofloxacin and the effect on the faecal flora of healthy volunteers. J Antimicrob Chemother. 1988 Sep;22 (Suppl 100):115–125. doi: 10.1093/jac/22.supplement_c.115. [DOI] [PubMed] [Google Scholar]
  12. Ludwig G., Pauthner H. Clinical experience with ofloxacin in upper and lower urinary tract infections. A comparison with co-trimoxazole and nitrofurantoin. Drugs. 1987;34 (Suppl 1):95–99. doi: 10.2165/00003495-198700341-00021. [DOI] [PubMed] [Google Scholar]
  13. Murray B. E., Rensimer E. R., DuPont H. L. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole. N Engl J Med. 1982 Jan 21;306(3):130–135. doi: 10.1056/NEJM198201213060302. [DOI] [PubMed] [Google Scholar]
  14. Norrby S. R. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis. 1990 May-Jun;12(3):458–467. doi: 10.1093/clinids/12.3.458. [DOI] [PubMed] [Google Scholar]
  15. Ode B., Walder M., Forsgren A. Failure of a single dose of 100 mg ofloxacin in lower urinary tract infections in females. Scand J Infect Dis. 1987;19(6):677–679. doi: 10.3109/00365548709117203. [DOI] [PubMed] [Google Scholar]
  16. Peddie B. A., Bailey R. R., Wells J. E. Resistance of urinary tract isolates of Escherichia coli to cotrimoxazole, sulphonamide, trimethoprim and ampicillin: an 11-year survey. N Z Med J. 1987 Jun 10;100(825):341–342. [PubMed] [Google Scholar]
  17. Rao D. S., Parfitt A. M., Villanueva A. R., Dorman P. J., Kleerekoper M. Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light-chain nephropathy. Another form of oncogenous osteomalacia. Am J Med. 1987 Feb;82(2):333–338. doi: 10.1016/0002-9343(87)90081-7. [DOI] [PubMed] [Google Scholar]
  18. Raz R., Genesin J., Gonen E., Shmilovitz M., Hefter H., Potasman I. Single low-dose ofloxacin for the treatment of uncomplicated urinary tract infection in young women. J Antimicrob Chemother. 1988 Dec;22(6):945–949. doi: 10.1093/jac/22.6.945. [DOI] [PubMed] [Google Scholar]
  19. Raz R., Rottensterich E., Hefter H., Kennes Y., Potasman I. Single-dose ciprofloxacin in the treatment of uncomplicated urinary tract infection in women. Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1040–1042. doi: 10.1007/BF01975166. [DOI] [PubMed] [Google Scholar]
  20. Schaeffer A. J., Sisney G. A. Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora. J Urol. 1985 Apr;133(4):628–630. doi: 10.1016/s0022-5347(17)49118-x. [DOI] [PubMed] [Google Scholar]
  21. Vellucci A., Bernardini G., Battaglia A. M., Battaglia P. Ofloxacin vs. cotrimoxazole in patients with complicated urinary tract infections. Int J Clin Pharmacol Ther Toxicol. 1987 May;25(5):279–281. [PubMed] [Google Scholar]
  22. Wolfson J. S., Hooper D. C. Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis. Antimicrob Agents Chemother. 1989 Oct;33(10):1655–1661. doi: 10.1128/aac.33.10.1655. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES